---
title: "CRSP SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for CRISPR Therapeutics (CRSP), with links to the SEC filings."
url: "https://tradytics.com/research/CRSP/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=CRSP&v=stock-11994868"
---

# CRSP financial statements and SEC filings

## CRSP annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $3.51M | -$664.57M | -$581.60M | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000119312526048957/0001193125-26-048957-index.htm) |
| 2024-12-31 | $37.31M | -$466.57M | -$366.25M | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000119312526048957/0001193125-26-048957-index.htm) |
| 2023-12-31 | $371.21M | -$222.54M | -$153.61M | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000119312526048957/0001193125-26-048957-index.htm) |
| 2022-12-31 | $1.20M | -$673.16M | -$650.17M | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000095017025017899/0000950170-25-017899-index.htm) |
| 2021-12-31 | $914.96M | $373.53M | $377.66M | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000095017024017571/0000950170-24-017571-index.htm) |
| 2020-12-31 | $719.00K | -$354.44M | -$348.87M | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000095017023003441/0000950170-23-003441-index.htm) |

## CRSP annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $2.27B | $343.43M | $1.92B | [10-Q](https://www.sec.gov/Archives/edgar/data/1674416/000119312526443665/0001193125-26-443665-index.htm) |
| 2024-12-31 | $2.24B | $309.95M | $1.93B | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000119312526048957/0001193125-26-048957-index.htm) |
| 2023-12-31 | $2.23B | $346.77M | $1.88B | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000095017025017899/0000950170-25-017899-index.htm) |
| 2022-12-31 | $2.24B | $367.58M | $1.88B | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000095017024017571/0000950170-24-017571-index.htm) |
| 2021-12-31 | $2.75B | $352.42M | $2.40B | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000095017023003441/0000950170-23-003441-index.htm) |
| 2020-12-31 | $1.83B | $163.73M | $1.66B | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000095017022001282/0000950170-22-001282-index.htm) |

## CRSP annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | -$345.01M | -$914.00K | $426.03M | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000119312526048957/0001193125-26-048957-index.htm) |
| 2024-12-31 | -$142.77M | -$1.90M | $331.98M | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000119312526048957/0001193125-26-048957-index.htm) |
| 2023-12-31 | -$260.38M | -$9.47M | $62.66M | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000119312526048957/0001193125-26-048957-index.htm) |
| 2022-12-31 | -$495.74M | -$37.19M | $38.59M | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000095017025017899/0000950170-25-017899-index.htm) |
| 2021-12-31 | $538.97M | -$81.70M | $250.94M | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000095017024017571/0000950170-24-017571-index.htm) |
| 2020-12-31 | -$238.37M | -$18.36M | $1.02B | [10-K](https://www.sec.gov/Archives/edgar/data/1674416/000095017023003441/0000950170-23-003441-index.htm) |

- [CRSP stock research](https://tradytics.com/research/CRSP)
- [CRSP financial summary](https://tradytics.com/research/CRSP/financials)
- [Read the data without JavaScript](https://tradytics.com/research/CRSP/fundamentals?snapshot=1)
